Physician profile
Edward G Barton
NPI 1285862375
$2,163.21
in general payments reported to CMS, 2019-2025
22 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $199 · 2021: $101 · 2022: $184 · 2023: $353 · 2024: $216 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048 · Education: $28.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.47 |
| Education | $28.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $585.74 | 2019-2020 | |
| Abbvie INC. | $481.64 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Pfizer INC. | $288.16 | 2023-2025 | |
| Lilly USA, LLC | $96.66 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $96.22 | 2020-2024 | Austedo Xr, Ajovy |
| Biogen, INC. | $70.29 | 2022-2025 | Skyclarys |
| Jazz Pharmaceuticals INC. | $61.05 | 2023 | |
| C2n Diagnostics, LLC | $48.52 | 2025 | Precivityad2 |
| Novartis Pharmaceuticals Corporation | $46.96 | 2019 | |
| Microtransponder, INC. | $46.06 | 2025 | |
| Ucb, INC. | $45.11 | 2019-2024 | Zilbrysq |
| Boston Scientific Corporation | $41.76 | 2023 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Travere Therapeutics, INC. | $37.96 | 2019-2022 | |
| Livanova USA, INC. | $37.16 | 2019-2021 | |
| Amgen INC. | $28.63 | 2025 | Uplizna |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.90 | 2021 | |
| Acadia Pharmaceuticals INC | $26.26 | 2024 | Daybue |
| Ge Healthcare | $24.13 | 2025 | |
| Sunovion Pharmaceuticals INC. | $21.20 | 2020 | |
| Inspire Medical Systems, INC. | $20.30 | 2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $16.77 | 2023 | Quviviq |
| Sun Pharmaceutical Industries INC. | $14.73 | 2023 | Yonsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.